Showing results (11-20 of 17) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 17 results.
Nature Communications|November 19, 2021
HER2 + breast cancers evade anti-HER2 therapy via a switch in driver pathwayAlison E Smith, Emanuela Ferraro, Anton Safonov, et al.
NPJ Precision Oncology|February 12, 2024
Genomic and epigenomic basis of breast invasive lobular carcinomas lacking CDH1 genetic alterationsHiginio Dopeso, Andrea M Gazzo, Fatemeh Derakhshan, et al.
The Journal of Pathology|February 3, 2016
Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progressionSalvatore Piscuoglio, Charlotte Ky Ng, Melissa Murray, et al.
Acta Neuropathologica Communications|September 17, 2024
Real-world experience with circulating tumor DNA in cerebrospinal fluid from patients with central nervous system tumorsRichard A Hickman, Alexandra M Miller, Bridget M Holle, et al.
Biorxiv : the Preprint Server for Biology|September 10, 2024
Tumor suppressor heterozygosity and homologous recombination deficiency mediate resistance to front-line therapy in breast cancerAnton Safonov, Antonio Marra, Chaitanya Bandlamudi, et al.
Archives of Pathology & Laboratory Medicine|January 20, 2024
Identification of Glandular (Acinar)/Tubule Formation in Invasive Carcinoma of the Breast: A Study to Determine Concordance Using the World Health Organization DefinitionYungtai Lo, Susan C Lester, Ian O Ellis, et al.
Nature|March 4, 2026
Homologous recombination deficiency and hemizygosity drive resistance in breast cancerAnton Safonov, Minna Lee, David N Brown, et al.
Pageof 2